Biological research and development is a hugely costly business for small and emerging biotechnology companies. The median R&D cost per drug, from data collected between 2009 to 2018, is estimated at $985 million.
Biological research and development is a hugely costly business for small and emerging biotechnology companies. The median R&D cost per drug, from data collected between 2009 to 2018, is estimated at $985 millionVery forward-looking piece 🙏 describing the digital life science lab 🤩 “It is not possible to simply introduce leading datascience techniques without undertaking the right digitalization steps in laboratory-level experiment design, execution and analysis.” 👍
This is relevant to and vice versa.
synthace The digitalization of R&D can potentially transform the life sciences, but it cannot succeed without experts collaborating to develop a vision of what a better working environment can look like. Lead author Markus Gershater goes behindthepaper
synthace Nature Biotech is publishing company white papers now?